HCAT
Health Catalyst, Inc. NASDAQ Listed Jul 25, 2019$1.59
Mkt Cap $117.4M
52w Low $0.95
15.6% of range
52w High $5.06
50d MA $1.38
200d MA $2.43
P/E (TTM)
-0.6x
EV/EBITDA
20.0x
P/B
0.4x
Debt/Equity
0.7x
ROE
-72.4%
P/FCF
-704.9x
RSI (14)
—
ATR (14)
—
Beta
1.81
50d MA
$1.38
200d MA
$2.43
Avg Volume
863.6K
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.
10897 South River Front Parkway · South Jordan, UT 84095 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | AMC | 0.09 | 0.08 | -11.1% | 1.79 | -22.9% | -26.3% | -31.8% | -34.6% | -35.2% | -31.8% | — |
| Nov 10, 2025 | AMC | 0.05 | 0.06 | +20.0% | 2.85 | +8.1% | -5.6% | -13.7% | -17.5% | -20.4% | -21.4% | — |
| Aug 7, 2025 | AMC | 0.03 | 0.04 | +33.3% | 3.69 | -21.4% | -23.3% | -26.8% | -18.7% | -12.7% | -20.6% | — |
| May 7, 2025 | AMC | 0.01 | 0.01 | +0.0% | 3.97 | +21.4% | +5.3% | +4.0% | +13.9% | +8.1% | +5.3% | — |
| Feb 26, 2025 | AMC | 0.11 | 0.04 | -63.6% | 4.94 | -3.8% | -11.1% | -5.5% | -6.9% | -8.5% | -7.9% | — |
| Nov 6, 2024 | AMC | 0.10 | 0.07 | -30.0% | 8.25 | -5.6% | +7.4% | -0.1% | +0.8% | -1.5% | +5.0% | — |
| Aug 7, 2024 | AMC | 0.09 | 0.12 | +33.3% | 5.48 | +18.6% | +37.8% | +21.4% | +16.1% | +17.7% | +15.3% | — |
| May 9, 2024 | AMC | 0.03 | 0.05 | +79.1% | 6.67 | -4.3% | -3.9% | +1.8% | +2.5% | +1.6% | +5.4% | — |
| Feb 22, 2024 | AMC | 0.00 | 0.02 | +2718.3% | 8.47 | -9.6% | -8.1% | -8.9% | -1.9% | -3.7% | -1.8% | — |
| Nov 2, 2023 | AMC | 0.01 | 0.03 | +275.3% | 7.37 | -2.0% | +3.1% | -1.8% | -2.3% | +0.1% | -6.2% | — |
| Aug 8, 2023 | AMC | 0.00 | 0.05 | +1448.9% | 12.95 | +4.5% | -3.8% | -4.3% | -0.7% | -1.9% | -1.9% | — |
| May 9, 2023 | AMC | 0.02 | 0.05 | +222.7% | 11.95 | -8.2% | -17.5% | -17.2% | -13.3% | -7.0% | -8.7% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18 | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $1.17 | $1.06 | -9.4% | -0.9% | +4.3% | +5.1% | +3.4% | -6.0% |
| Mar 13 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $1.79 | $1.38 | -22.9% | -26.3% | -31.8% | -34.6% | -35.2% | -31.8% |
| Mar 13 | Canaccord Genuity | Maintains | Buy → Buy | — | $1.79 | $1.38 | -22.9% | -26.3% | -31.8% | -34.6% | -35.2% | -31.8% |
| Mar 13 | Stifel | Maintains | Hold → Hold | — | $1.79 | $1.38 | -22.9% | -26.3% | -31.8% | -34.6% | -35.2% | -31.8% |
| Mar 13 | Citigroup | Maintains | Neutral → Neutral | — | $1.79 | $1.38 | -22.9% | -26.3% | -31.8% | -34.6% | -35.2% | -31.8% |
| Mar 13 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $1.79 | $1.38 | -22.9% | -26.3% | -31.8% | -34.6% | -35.2% | -31.8% |
| Jan 9 | Citigroup | Maintains | Neutral → Neutral | — | $2.45 | $2.46 | +0.4% | +0.8% | +0.4% | -2.0% | -5.7% | -4.5% |
| Nov 11 | Wells Fargo | Maintains | Overweight → Overweight | — | $2.85 | $3.08 | +8.1% | -5.6% | -13.7% | -17.5% | -20.4% | -21.4% |
| Nov 11 | Stifel | Maintains | Hold → Hold | — | $2.85 | $3.08 | +8.1% | -5.6% | -13.7% | -17.5% | -20.4% | -21.4% |
| Nov 11 | Citigroup | Maintains | Neutral → Neutral | — | $2.85 | $3.08 | +8.1% | -5.6% | -13.7% | -17.5% | -20.4% | -21.4% |
| Oct 8 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $2.85 | $2.82 | -1.1% | +0.0% | -2.5% | -7.0% | -4.9% | +1.8% |
| Oct 8 | Evercore ISI | Maintains | In Line → In Line | — | $2.85 | $2.82 | -1.1% | +0.0% | -2.5% | -7.0% | -4.9% | +1.8% |
| Oct 7 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $2.96 | $2.96 | +0.0% | -3.7% | -3.7% | -6.1% | -10.5% | -8.4% |
| Sep 5 | BTIG | Maintains | Neutral → Neutral | — | $3.30 | $3.31 | +0.3% | +2.4% | +2.4% | +3.0% | -1.2% | -1.8% |
| Aug 29 | Canaccord Genuity | Maintains | Buy → Buy | — | $3.65 | $3.64 | -0.3% | -7.1% | -6.8% | -11.2% | -9.6% | -7.4% |
| Aug 28 | Evercore ISI | Maintains | In Line → In Line | — | $3.69 | $3.68 | -0.3% | -1.1% | -8.1% | -7.9% | -12.2% | -10.6% |
| Aug 27 | Piper Sandler | Downgrade | Overweight → Neutral | — | $3.50 | $3.27 | -6.6% | +5.4% | +4.3% | -3.1% | -2.9% | -7.4% |
| Aug 11 | Wells Fargo | Maintains | Overweight → Overweight | — | $2.83 | $2.83 | +0.0% | -4.6% | +6.0% | +13.8% | +3.5% | +3.2% |
| Aug 8 | Stifel | Maintains | Hold → Hold | — | $3.69 | $2.90 | -21.4% | -23.3% | -26.8% | -18.7% | -12.7% | -20.6% |
| Aug 8 | Cantor Fitzgerald | Downgrade | Overweight → Neutral | — | $3.69 | $2.90 | -21.4% | -23.3% | -26.8% | -18.7% | -12.7% | -20.6% |
| Aug 8 | Citigroup | Downgrade | Buy → Neutral | — | $3.69 | $2.90 | -21.4% | -23.3% | -26.8% | -18.7% | -12.7% | -20.6% |
| Jul 9 | Evercore ISI | Maintains | In Line → In Line | — | $4.04 | $4.06 | +0.5% | -0.2% | -1.2% | -3.7% | -4.5% | -7.4% |
| May 8 | Stifel | Maintains | Hold → Hold | — | $3.97 | $4.82 | +21.4% | +5.3% | +4.0% | +13.9% | +8.1% | +5.3% |
| May 8 | Canaccord Genuity | Maintains | Buy → Buy | — | $3.97 | $4.82 | +21.4% | +5.3% | +4.0% | +13.9% | +8.1% | +5.3% |
| Apr 25 | Citigroup | Maintains | Buy → Buy | — | $3.98 | $3.96 | -0.5% | +3.0% | +2.0% | +2.3% | -0.8% | +0.3% |
| Apr 16 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $3.70 | $3.62 | -2.2% | +1.4% | +3.8% | -3.2% | -1.1% | +5.4% |
| Apr 9 | Evercore ISI | Downgrade | Outperform → In Line | — | $3.82 | $3.70 | -3.1% | +5.2% | +0.3% | +2.9% | +0.5% | -3.1% |
| Mar 6 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $4.55 | $4.38 | -3.7% | -2.6% | -5.7% | -12.7% | -8.4% | -2.6% |
| Feb 27 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $4.94 | $4.75 | -3.8% | -11.1% | -5.5% | -6.9% | -8.5% | -7.9% |
| Feb 27 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $4.94 | $4.75 | -3.8% | -11.1% | -5.5% | -6.9% | -8.5% | -7.9% |
| Feb 27 | Stifel | Maintains | Hold → Hold | — | $4.94 | $4.75 | -3.8% | -11.1% | -5.5% | -6.9% | -8.5% | -7.9% |
| Feb 11 | Piper Sandler | Maintains | Overweight → Overweight | — | $5.75 | $5.62 | -2.3% | -4.3% | -5.4% | -3.5% | -5.7% | -6.1% |
| Jan 21 | Wells Fargo | Maintains | Overweight → Overweight | — | $5.49 | $5.50 | +0.2% | +3.5% | +2.2% | +5.5% | +5.1% | +3.5% |
| Jan 21 | Canaccord Genuity | Maintains | Buy → Buy | — | $5.49 | $5.50 | +0.2% | +3.5% | +2.2% | +5.5% | +5.1% | +3.5% |
| Jan 15 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $5.90 | $6.08 | +3.1% | -2.4% | -6.8% | -6.9% | -3.7% | -4.9% |
| Jan 10 | Citigroup | Maintains | Buy → Buy | — | $7.36 | $7.13 | -3.1% | -6.4% | -11.8% | -19.8% | -21.7% | -25.3% |
| Jan 8 | KeyBanc Capital Markets | Upgrade | Sector Weight → Overweight | — | $6.98 | $7.27 | +4.2% | +5.4% | -1.3% | -7.0% | -15.5% | -17.5% |
| Nov 26 | Piper Sandler | Maintains | Overweight → Overweight | — | $8.52 | $8.59 | +0.8% | -0.2% | +1.5% | +3.6% | +5.9% | -6.8% |
| Nov 14 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $8.66 | $8.62 | -0.5% | -2.4% | -11.7% | -13.0% | -12.9% | -15.0% |
| Nov 13 | Citigroup | Maintains | Buy → Buy | — | $8.13 | $8.39 | +3.2% | +6.5% | +3.9% | -5.9% | -7.4% | -7.3% |
| Nov 7 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $8.25 | $7.79 | -5.6% | +7.4% | -0.1% | +0.8% | -1.5% | +5.0% |
| Oct 8 | Evercore ISI | Maintains | Outperform → Outperform | — | $7.62 | $7.77 | +2.0% | +2.8% | +3.8% | +3.0% | +6.8% | +8.0% |
| Oct 4 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $7.63 | $7.83 | +2.6% | +0.9% | -0.1% | +2.6% | +3.7% | +2.9% |
| Sep 20 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $8.83 | $8.80 | -0.3% | -1.6% | -7.1% | -8.5% | -6.8% | -5.0% |
| Sep 4 | JP Morgan | Maintains | Overweight → Overweight | — | $7.25 | $7.39 | +1.9% | +4.0% | +1.8% | +0.6% | +3.2% | +8.3% |
| Aug 26 | Piper Sandler | Maintains | Overweight → Overweight | — | $7.27 | $7.39 | +1.7% | -1.5% | -5.0% | -6.2% | -4.8% | -1.1% |
| Aug 20 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $6.84 | $6.84 | +0.0% | +3.1% | +4.5% | +3.2% | +6.3% | +4.7% |
| Aug 9 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $7.55 | $7.49 | -0.8% | -11.9% | -15.8% | -14.6% | -16.3% | -10.3% |
| Aug 8 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $5.48 | $6.50 | +18.6% | +37.8% | +21.4% | +16.1% | +17.7% | +15.3% |
| Jul 9 | Evercore ISI | Maintains | Outperform → Outperform | — | $6.22 | $6.15 | -1.1% | -1.3% | -5.8% | +2.3% | +4.0% | +4.7% |
No insider trades available.
8-K · 5.02
!!! Very High
Health Catalyst, Inc -- 8-K 5.02: Executive Change
Health Catalyst appointed a new Chief People Officer, indicating potential leadership restructuring that investors should monitor for impacts on organizational stability and strategic execution.
Apr 27
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
HCAT's executive leadership transition effective February 12, 2026, signals potential strategic shift or instability that could impact operational continuity and investor confidence until new management's direction becomes clear.
Apr 3
8-K
Unknown — 8-K Filing
Health Catalyst reported full-year 2025 results showing its data analytics platform's market traction, which investors should monitor for revenue growth acceleration and path to profitability in the healthcare technology sector.
Mar 12
8-K · 5.02
!!! Very High
Health Catalyst, Inc -- 8-K 5.02: Executive Change
Health Catalyst appointed Ben Albert as CEO effective February 12, 2026, replacing the previous leadership and positioning the healthcare analytics company under new strategic direction.
Feb 18
Data updated apr 25, 2026 1:08pm
· Source: massive.com